Translation is a team sport and NCATS wants to play

Program Overview:
Meet with the newest institute at the NIH called The National Center for Advancing Translational Science (NCATS). By design, NCATS was formed to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster.

NCATS directly addresses the obstacles scientists face when developing a novel drug, device or other intervention. They are committed to uncovering new technologies and other approaches that could greatly accelerate the development and deployment of solutions that all translational researchers can use.

The NCATS approach is distinct in many ways and has already made a significant impact. Successes include 19 INDs that have been cleared by the FDA, twelve projects have been evaluated in clinical trials, and three agents have gone as far as Phase II human clinical trials. Additionally, third-party investors have licensed seven agents that have been developed through NCATS programs.

Join us to learn more about NCATS and their innovative approach. Following an overview of NCATS\’ opportunities and key areas of interest, don\’t miss the opportunity to introduce yourself during the networking lunch. Finally, for those companies who apply online and are approved, one-on-one meetings with NCATS will provide a forum to further discuss your company.

NCATS is seeking to collaborate with companies focusing on translating bench top discoveries to clinical hypothesis testing. Leaders from the life science industry are encouraged to apply today to meet with a representative from NCATS!

Agenda:
10:00 AM | Registration & Networking
10:30 AM | Presentation & Q&A
12:00 PM | Lunch & Networking
1:00 PM | One-on-one Meetings*
4:30 PM | Program Close

*Companies must apply ahead of time and be approved for a one-on-one meeting. The application period ends October 15. APPLY HERE

NIH NCATS Participating Representative:
John McKew, Ph.D. | Acting Scientific Director, Division of Preclinical Innovation, National Center for Advancing Translational Science, National Institutes of Health read bio»

About the National Center for Advancing Translational Sciences :
The National Center for Advancing Translational Sciences (NCATS) is the newest of 27 Institutes and Centers (ICs) at the National Institutes of Health (NIH). This Center was established in December 2011 to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster. The mission of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. Read more about NCATS»

Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until November 4 (or full).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on on Wednesday, October 15, 2014. Your application will be reviewed and you will be notified of acceptance on Wednesday, October 29, 2014. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Location:
MassBio HQ
300 Technology Square, 8th Floor
Collaboration Room
Cambridge, MA 02139